HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (25) Citing Articles via Google Scholar Google Scholar Articles by Blasi, F. Search for Related Content PubMed PubMed Citation Articles by Blasi, F.

Atypical pathogens and respiratory tract infections

Institute of Respiratory Diseases, University of Milan, IRCCS Ospedale Maggiore, Milan, Italy

CORRESPONDENCE: F. Blasi, Istituto di Tisiologia e Malattie dell'Apparato Respiratorio, Universita degli Studi Milano, Pad. Litta, IRCCS Ospedale Maggiore di Milano, Via F. Sforza 35, 20122, Milano, Italy. Fax: 39 0250320628. E-mail: francesco.blasi@unimi.it

Keywords: atypical, Chlamydia, Legionella, Mycoplasma, respiratory-tract infections

Received: December 8, 2003
Accepted February 23, 2004

Abstract

The atypical respiratory pathogens Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila are now recognised as a significant cause of acute respiratory-tract infections, implicated in community-acquired pneumonia, acute exacerbations of chronic bronchitis, asthma, and less frequently, upper respiratory-tract infections.

Chronic infection with C. pneumoniae is common among patients with chronic obstructive pulmonary disease and may also play a role in the natural history of asthma, including exacerbations. The lack of a gold standard for diagnosis of these pathogens still handicaps the current understanding of their true prevalence and role in the pathogenesis of acute and chronic respiratory infections.

While molecular diagnostic techniques, such as polymerase chain reaction, offer improvements in sensitivity, specificity and rapidity over culture and serology, the need remains for a consistent and reproducible diagnostic technique, available to all microbiology laboratories.

Current treatment guidelines for community-acquired pneumonia recognise the importance of atypical respiratory pathogens in its aetiology, for which macrolides are considered suitable first-line agents. The value of atypical coverage in antibiotic therapy for acute exacerbations of chronic bronchitis and exacerbations of asthma is less clear, while there is no evidence to suggest that atypical pathogens should be covered in antibiotic treatment of upper respiratory-tract infections.

This article has been cited by other articles:

				J. D. Brunstein, C. L. Cline, S. McKinney, and E. Thomas Evidence from Multiplex Molecular Assays for Complex Multipathogen Interactions in Acute Respiratory Infections J. Clin. Microbiol., January 1, 2008; 46(1): 97 - 102. [Abstract] [Full Text] [PDF]

				N. Miyashita, Y. Obase, K. Ouchi, K. Kawasaki, Y. Kawai, Y. Kobashi, and M. Oka Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit J. Med. Microbiol., December 1, 2007; 56(12): 1625 - 1629. [Abstract] [Full Text] [PDF]

				T. M. A. Wilkinson Host Pathogen Interactions during COPD Exacerbations: Moving on from Microbiology by Numbers? Am. J. Respir. Crit. Care Med., August 15, 2007; 176(4): 323 - 325. [Full Text] [PDF]